Patent · US Active

Rapid, informative diagnostic assay for influenza viruses including H5N1

US7989185B2 · kind B2 · utility

5Cited by
7References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 27, 2007
Grant dateAug 2, 2011
Priority date
Expiry dateSep 24, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/701
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A rapid diagnostic assay for influenza virus, particularly avian influenza and more particularly H5N1, is described. The assay is based on amplification of a significant portion of the hemagglutinin (HA) gene and sequencing of several loci within the HA gene, using techniques which can obtain real time sequence information from multiple sites of a target DNA, in particular pyrosequencing and bioluminescence regenerative cycle. The assay contemplates the use of information-rich subsequences within the HA gene, e.g., (1) a glycosylation sequon; (2) receptor binding site; and (3) HA1/HA2 cleavage site. Other subsequences for sequencing include strain and clade markers, which vary among H5N1 strains.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.